Over the past year, prescription weight loss medications have reshaped the trajectory of the aesthetics industry. What began as a breakthrough in metabolic health has rapidly expanded into something much bigger, influencing facial aging, body composition, longevity, and the way aesthetic clinics support their patients.
In this episode, Dr. Randi sits down with NewBeauty CEO Mike Glaicar to discuss how the rise of GLP-1 medications is changing the landscape of beauty, wellness, and patient expectations. As millions of people begin their weight loss journeys, many are encountering unexpected aesthetic changes such as facial volume loss, skin laxity, and hair thinning, creating a growing need for guidance and education.
That need led to the creation of Step Beyond the Scale, a NewBeauty platform designed to bring credible, expert-backed insight to the GLP-1 conversation. Rather than relying on fragmented social media advice or limited pharmaceutical messaging, the platform brings together leading experts to help patients better understand and navigate these changes.
In this conversation, they explore:
• The aesthetic changes patients are experiencing during rapid weight loss
• Why NewBeauty launched Step Beyond the Scale
• How expert-driven education helps patients navigate the GLP-1 journey
• The growing connection between metabolic health, aesthetics, and longevity
• How clinics can better support patients throughout their transformation
Grounded in consumer data, physician insight, and the evolving realities of modern aesthetics, this episode offers a clear look at how GLP-1 medications are influencing the industry, and why education will play a critical role in what comes next.
---
Listeners should not rely on any content from this podcast as a substitute for professional medical advice. Always consult a licensed physician or qualified healthcare provider regarding any medical concerns, treatments, or decisions. This podcast does not endorse or guarantee the safety or efficacy of any products, procedures, or services discussed.
This podcast is not intended for individuals under the age of 18.
Neither the host nor any guests assume liability for any loss, injury, or damage resulting from the use or application of the information discussed on this show.